These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
695 related articles for article (PubMed ID: 30168179)
1. Upregulation of lncRNA snoRNA host gene 6 regulates NUAK family SnF1-like kinase-1 expression by competitively binding microRNA-125b and interacting with Snail1/2 in bladder cancer. Wang C; Tao W; Ni S; Chen Q J Cell Biochem; 2019 Jan; 120(1):357-367. PubMed ID: 30168179 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Xue M; Pang H; Li X; Li H; Pan J; Chen W Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536 [TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p. Yan K; Tian J; Shi W; Xia H; Zhu Y Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446 [TBL] [Abstract][Full Text] [Related]
4. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis. Du F; Guo T; Cao C Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782 [TBL] [Abstract][Full Text] [Related]
5. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells. Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245 [TBL] [Abstract][Full Text] [Related]
6. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer. Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562 [TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG6 promotes breast cancer progression and epithelial-mesenchymal transition via miR-543/LAMC1 axis. Wang YQ; Huang G; Chen J; Cao H; Xu WT Breast Cancer Res Treat; 2021 Jul; 188(1):1-14. PubMed ID: 33782812 [TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328 [No Abstract] [Full Text] [Related]
9. LncRNA SNHG6 regulating Hedgehog signaling pathway and affecting the biological function of gallbladder carcinoma cells through targeting miR-26b-5p. Liu XF; Wang K; Du HC Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7598-7611. PubMed ID: 32744686 [TBL] [Abstract][Full Text] [Related]
10. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA. Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SNHG6 promotes glioma tumorigenesis by sponging miR-101-3p. Meng Q; Yang BY; Liu B; Yang JX; Sun Y Int J Biol Markers; 2018 May; 33(2):148-155. PubMed ID: 29799357 [TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis. Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer. Lv P; Qiu X; Gu Y; Yang X; Xu X; Yang Y Biomed Pharmacother; 2019 Feb; 110():294-301. PubMed ID: 30522015 [TBL] [Abstract][Full Text] [Related]
14. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer. Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010 [TBL] [Abstract][Full Text] [Related]
15. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA. Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971 [TBL] [Abstract][Full Text] [Related]
16. SPI1-induced upregulation of lncRNA SNHG6 promotes non-small cell lung cancer via miR-485-3p/VPS45 axis. Gao N; Ye B Biomed Pharmacother; 2020 Sep; 129():110239. PubMed ID: 32590190 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis. Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716 [TBL] [Abstract][Full Text] [Related]
18. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer. Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells. Miao X; Gao H; Liu S; Chen M; Xu W; Ling X; Deng X; Rao C Int J Biol Macromol; 2018 Jan; 106():234-240. PubMed ID: 28780419 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA Unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells. Lv J; Fan HX; Zhao XP; Lv P; Fan JY; Zhang Y; Liu M; Tang H Cancer Lett; 2016 Nov; 382(2):166-175. PubMed ID: 27597739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]